8%
versus 216.6, P = 0.048. CD25high cells formed about 7% of CD4+/CD25+ cells and the proportion differed significantly screening assay between investigated groups being lower in the patients than in controls (5.2% versus 7.5%, P = 0.03). The proportion of CTLA4+ cells as a percentage of CD25+ cells was significantly higher in the patients when compared with healthy persons (10.4% versus 4.7%, P = 0.014) (Fig. 2c). The mean fluorescence of CTLA4 on lymphocytes in patients was 189% and was higher than in healthy subjects 150%, difference not significant. There were no differences in the lymphocyte subtypes between smokers and nonsmokers in the group of patients and of controls, as well. The proportion of T-cell subpopulations did not differ between smokers and ex-smokers in patients Ponatinib ic50 with COPD. There was an inverse relation of the proportion of T-helper cells with smoking history expressed as pack years smoked (R = –0.55, P < 0.05) in the COPD group. The mean serum concentration of adiponectin was 15.4 ± 13.3 μg/ml in COPD patients and 8.5 ± 7.58 μg/ml in controls (P = 0.021) (Fig. 3). The mean adiponectin to body mass index (BMI) ratio was
0.38 ± 0.27 in patients versus 0.28 ± 0.14 in controls, difference not significant. The proportion of CD3+ cells correlated with disease duration (R = 0.7, P < 0.05). There was a significant correlation of the proportion of CTLA4+ cells with the proportion of CD8+/CD25+ (R = 0.62, P < 0.05). We did not find no more relevant correlations of proportion of cell subtypes with
demographic data. Especially no correlation of the proportion of lymphocyte subtypes with the age of investigated persons was observed. The mean age in the patients group was slightly higher than in the control group. However, after grouping Morin Hydrate investigated persons into the groups in comparable age, the differences in the proportion of cells noted above remained significant. No significant correlations of results of pulmonary function tests with proportion of cell subpopulations were found. We observed significant negative correlation of adiponectin concentration with BMI in the group of patients (R = –0.85, P < 0.05). The adiponectin/BMI ratio correlated with the decrease of FEV1% and with decrease of FEV1%FVC (R = –0.59, P < 0.05). The adiponectin/ BMI ratio correlated with proportion of T-helper cells (R = 0.6, P < 0.05). The systemic inflammation in the course of COPD is a fact but its aetiology and pathogenesis remain unclear and are recently widely investigated [2]. In this study, we presented one fragment of the complicated inflammatory pathways: some elements that are known to be active in autoregulation of the immune response. We found significant alterations in the population of T lymphocytes with regulatory properties in patients with mild/moderate COPD.
Related posts:
- Statistical analyses were performed with SAS 913 (SAS Institute
- 7 versus 22 1) than patients who never received low-dose corticos
- In this preliminary study, the results showed that there was an u
- A median of 2 6% (range 1 0–12 6%) of B-lymphocytes were TACI-pos
- 36 and 0 39 mm for NMIA and SIA versus 0 86 and 2 56 mm determine